Impact of high glucose on metastasis of colon cancer cells

World Journal of Gastroenterology

Volumn 21, Issue 7, 2015, Pages 2047-2057

  Lin, Cheng Yao ^a,b   Lee, Chih Hui ^c   Huang, Chien Cheng ^a,d   Lee, Song Tay ^d   Guo, How Ran ^c   Su, Shih Bin ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Colorectal cancer; Glucose; Matrix metalloproteinase 9; Metastasis; Signal transducer and activator of transcription 3

Indexed keywords

GELATINASE B; GLUCOSE; MANNITOL; PROTEIN INHIBITOR; SMALL INTERFERING RNA; STAT3 PROTEIN; STATTIC; UNCLASSIFIED DRUG; MMP9 PROTEIN, RAT; STAT3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CELL LINE; CELL BEHAVIOR ASSAY; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; COLON CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CT 26 CELL LINE; DRUG TARGETING; GLUCOSE INTAKE; METASTASIS POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; WOUND HEALING ASSAY; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; COLORECTAL TUMOR; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; RNA INTERFERENCE; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFECTION;

EID: 84922717411     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i7.2047     Document Type: Article

References (43)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236 [PMID: 21685461 DOI: 10.3322/caac.20121]
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420-1425 [PMID: 15467030 DOI: 10.1093/jnci/djh275]
3. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34 [PMID: 16680569 DOI: 10.1007/s10555-006-7886-9]
4. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494 [PMID: 10419448 DOI: 10.1074/jbc.274.31.21491]
5. Farina AR, Mackay AR. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. Cancers (Basel) 2014; 6: 240-296 [PMID: 24473089 DOI: 10.3390/cancers6010240]
6. Chu D, Zhao Z, Zhou Y, Li Y, Li J, Zheng J, Zhao Q, Wang W. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol 2012; 19: 318-325 [PMID: 21455597 DOI: 10.1245/s10434-011-1686-3]
7. Tutton MG, George ML, Eccles SA, Burton S, Swift RI, Abulafi AM. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 2003; 107: 541-550 [PMID: 14520690 DOI: 10.1002/ijc.11436]
8. Aaronson DS, Horvath CM. A road map for those who don't know JAK-STAT. Science 2002; 296: 1653-1655 [PMID: 12040185 DOI: 10.1126/science.1071545]
9. Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Haematol 2001; 67: 63-71 [PMID: 11722592]
10. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798-809 [PMID: 19851315 DOI: 10.1038/nrc2734]
11. Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog 2013; 52: 155-166 [PMID: 22121102 DOI: 10.1002/mc.21841]
12. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002; 62: 6659-6666 [PMID: 12438264]
13. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 2011; 106: 1911-1921; quiz 1922 [PMID: 21912438 DOI: 10.1038/ajg.2011.301]
14. Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012; 57: 1576-1585 [PMID: 22350783 DOI: 10.1007/s10620-012-2055-1]
15. Huang YC, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 2011; 137: 211-220 [PMID: 20387072 DOI: 10.1007/s00432-010-0879-7]
16. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30: 53-59 [PMID: 22124092 DOI: 10.1200/jco.2011.38.0303]
17. Takatani-Nakase T, Matsui C, Maeda S, Kawahara S, Takahashi K. High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLoS One 2014; 9: e90136 [PMID: 24587242 DOI: 10.1371/journal.pone.0090136]
18. Liu Z, Jia X, Duan Y, Xiao H, Sundqvist KG, Permert J, Wang F. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration. Cancer Biol Ther 2013; 14: 428-435 [PMID: 23377827 DOI: 10.4161/cbt.23786]
19. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 2006; 85: 220-225 [PMID: 16498067]
20. Wu KJ, Zeng J, Zhu GD, Zhang LL, Zhang D, Li L, Fan JH, Wang XY, He DL. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacol Sin 2009; 30: 1162-1168 [PMID: 19578386 DOI: 10.1038/aps.2009.94]
21. Hoang AM, Oates TW, Cochran DL. In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000; 71: 1270-1277 [PMID: 10972642 DOI: 10.1902/jop.2000.71.8.1270]
22. Lackler KP, Cochran DL, Hoang AM, Takacs V, Oates TW. Development of an in vitro wound healing model for periodontal cells. J Periodontol 2000; 71: 226-237 [PMID: 10711613 DOI: 10.1902/jop.2000.71.2.226]
23. Fang Y, Svoboda KK. Nicotine inhibits human gingival fibroblast migration via modulation of Rac signalling pathways. J Clin Periodontol 2005; 32: 1200-1207 [PMID: 16268995 DOI: 10.1111/j.1600-051X.2005.00845.x]
24. JOSLIN EP, LOMBARD HL, BURROWS RE, MANNING MD. Diabetes and cancer. N Engl J Med 1959; 260: 486-488 [PMID: 13632915 DOI: 10.1056/nejm195903052601007]
25. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685 [PMID: 20587728 DOI: 10.2337/dc10-0666]
26. Poulson J. The management of diabetes in patients with advanced cancer. J Pain Symptom Manage 1997; 13: 339-346 [PMID: 9204654]
27. Wulaningsih W, Holmberg L, Garmo H, Zethelius B, Wigertz A, Carroll P, Lambe M, Hammar N, Walldius G, Jungner I, Van Hemelrijck M. Serum glucose and fructosamine in relation to risk of cancer. PLoS One 2013; 8: e54944 [PMID: 23372798 DOI: 10.1371/journal.pone.0054944]
28. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009; 15: 5141-5148 [PMID: 19891012]
29. Ortiz AP, Thompson CL, Chak A, Berger NA, Li L. Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer 2012; 118: 1774-1781 [DOI: 10.1002/cncr.26454]
30. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992; 90: 1323-1327 [PMID: 1401068 DOI: 10.1172/jci115997]
31. Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2001; 280: E23-E30 [PMID: 11120655]
32. Ramadoss P, Unger-Smith NE, Lam FS, Hollenberg AN. STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol Endocrinol 2009; 23: 827-837 [PMID: 19264844 DOI: 10.1210/me.2008-0264]
33. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 2004; 10: 168-174 [PMID: 14716305 DOI: 10.1038/nm980]
34. Tang H, Xie MH, Lei Y, Zhou L, Xu YP, Cai JG. The roles of aerobic exercise training and suppression IL-6 gene expression by RNA interference in the development of insulin resistance. Cytokine 2013; 61: 394-405 [PMID: 23294974 DOI: 10.1016/j.cyto.2012.11.027]
35. Du J, Wang L, Liu X, Zhou H, Fan Q, Luo J, Yao L, Wang J, Feng J, Ma J. Janus kinase 2/signal transducers and activators of transcription signal inhibition regulates protective effects of probucol on mesangial cells treated with high glucose. Biol Pharm Bull 2010; 33: 768-772 [PMID: 20460752]
36. Scheele C, Nielsen S, Kelly M, Broholm C, Nielsen AR, Taudorf S, Pedersen M, Fischer CP, Pedersen BK. Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One 2012; 7: e39657 [PMID: 22761857 DOI: 10.1371/journal.pone.0039657]
37. Dechow TN, Pedranzini L, Leitch A, Leslie K, Gerald WL, Linkov I, Bromberg JF. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc Natl Acad Sci USA 2004; 101: 10602-10607 [PMID: 15249664 DOI: 10.1073/pnas.0404100101]
38. Kim JE, Kim HS, Shin YJ, Lee CS, Won C, Lee SA, Lee JW, Kim Y, Kang JS, Ye SK, Chung MH. LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression. Exp Mol Med 2008; 40: 514-522 [PMID: 18985009 DOI: 10.3858/emm.2008.40.5.514]
39. Syed ZA, Yin W, Hughes K, Gill JN, Shi R, Clifford JL. HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop. BMC Cancer 2011; 11: 180 [PMID: 21595927 DOI: 10.1186/1471-2407-11-180]
40. Wang L, Luo J, He S. Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release. BMC Cell Biol 2007; 8: 14 [PMID: 17480240 DOI: 10.1186/1471-2121-8-14]
41. Schröer N, Pahne J, Walch B, Wickenhauser C, Smola S. Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res 2011; 71: 87-97 [PMID: 21199798 DOI: 10.1158/0008-5472.CAN-10-2193]
42. Taguchi A, Kawana K, Tomio K, Yamashita A, Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, Kojima S, Adachi K, Matsumoto Y, Arimoto T, Wada-Hiraike O, Oda K, Kang JX, Arai H, Arita M, Osuga Y, Fujii T. Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo. PLoS One 2014; 9: e89605 [PMID: 24586907 DOI: 10.1371/journal.pone.0089605]
43. Koskensalo S, Hagström J, Linder N, Lundin M, Sorsa T, Louhimo J, Haglund C. Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer. BMC Clin Pathol 2012; 12: 24 [PMID: 23216739 DOI: 10.1186/1472-6890-12-24]